2Fazio S,Palmieri E A,Lombardi G,et al.Effects of thyroid hormone on the cardiovascular system[J].Recent Progress in Hormone Research,2004,59(1):31-50.
3Andrade VA,Gross JL,Maia AL.The effect of methimazole pretreatment on the efficacy of radioactive iodine therapy in Graves'hyperthyroidism:one-year follow-up of a prospective,randomized study[J].The Journal of Clinical Endocrinology&Metabolism,2001,86(8):3488-3493.
4Miyauchi S,Matsuura B,Onji M.Increased Levels of Serum lnterleukin-18 in Graves'Disease[J].Thyroid,2000,10(9):815-819.
5Aniszewski JP,Valyasevi RW,Bahn RS.Relationship between disease duration and predominant orbital T cell subset in Graves'ophthalmopathy[J].The Journal of Clinical Endocrinology&Metabolism,2000,85(2):776-780.
6Okumura M,Hidakay OH,Matsuzuka F,et al.CD30expression and interleukin-4 and interferon-y production of intrathyroidal lymphocytes in Graves'disease[J].Thyroid,1999,9(4):333-339.
7Bschor T,Baethge C,Adli M,et al.Hypothalamic-pituitarythyroid system activity during lithium augmentation therapy in patients with unipolar major depression[J].Journal of Psychiatry and Neuroscience,2003,28(3):210.
8Strigari L,Sciuto R,Benassi M,et al.A NTCP approach for estimating the outcome in radioiodine treatment of hyperthyroidism[J].Medical physics,2008,35(9):3903-3910.
9Hurley JR.Orbitopathy after treatment of Graves'disease[J].Journal of Nuclear Medicine,1994,35(5):918-920.
10Giovanella L,De Palma D,Ceriani L,et al.Radioiodine treatment of hyperthyroidism using a simplified dosimetric approach.Clinical results[J].La Radiologia Medica,2000,100(6):480-483.
